Human genetic and metabolite variation reveals that methylthioadenosine is a prognostic biomarker and an inflammatory regulator in sepsis.

Wang, Liuyang; Ko, Emily R; Gilchrist, James J; Pittman, Kelly J; Rautanen, Anna; Pirinen, Matti; Thompson, J Will; Dubois, Laura G; Langley, Raymond J; Jaslow, Sarah L; +15 more... Salinas, Raul E; Rouse, D Clayburn; Moseley, M Arthur; Mwarumba, Salim; Njuguna, Patricia; Mturi, Neema; Wellcome Trust Case Control Consortium 2; Kenyan Bacteraemia Study Group; Williams, Thomas N; Scott, J Anthony G; Hill, Adrian VS; Woods, Christopher W; Ginsburg, Geoffrey S; Tsalik, Ephraim L; Ko, Dennis C; (2017) Human genetic and metabolite variation reveals that methylthioadenosine is a prognostic biomarker and an inflammatory regulator in sepsis. Science advances, 3 (3). e1602096-. ISSN 2375-2548 DOI: https://doi.org/10.1126/sciadv.1602096

Permanent Identifier

Use this Digital Object Identifier when citing or linking to this resource.

https://doi.org/10.1126/sciadv.1602096

Abstract

Share

Download

Filename: 1602096.PMC5342653.pdf

Licence: Creative Commons: Attribution 3.0

Download
[img]

Downloads

View details

Metrics & Citations


Google Scholar